PMDA drug package insert
プログラフ顆粒0.2mg
PMDA Prescription drug · アステラス製薬株式会社 · package insert Jun 24, 2026
Key facts
| Brand names | プログラフ顆粒0.2mg, プログラフ顆粒1mg |
|---|---|
| Nonproprietary names | タクロリムス水和物 |
| Companies | 製造販売／アステラス製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 免疫抑制剤 |
| Therapeutic category codes | 873999 |
| YJ codes | 3999014D1022, 3999014D2029 |
| Approval numbers | 21300AMZ00031, 21300AMZ00032 |
| Package insert edition | 第5版 |
| Package insert date | Jun 24, 2026 |
| PMDA document key | 800126_3999014D1022_3 |
| PMDA company code | 800126 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: